We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

48 hedge funds and large institutions have $45M invested in ALPS Medical Breakthroughs ETF in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.29% less ownership

Funds ownership: 29.35%27.06% (-2.3%)

13% less funds holding

Funds holding: 5548 (-7)

25% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 20

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

47% less capital invested

Capital invested by funds: $84.4M → $45M (-$39.4M)

Holders
48
Holders Change
-7
Holders Change %
-12.73%
% of All Funds
1.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
15
Reduced
20
Closed
13
Calls
$839K
Puts
Net Calls
+$839K
Net Calls Change
+$822K

SBIO Hedge Fund Activity: Q4 2018 in Review

48 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2018, worth a combined $45M — down 47% from $84.4M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SBIO and 8 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 15 added.

The largest buyer was Bouchey Financial Group, adding an estimated $3.7M. The largest seller was Bank of America, cutting an estimated $8.39M.

  • 48 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2018, down from 55 in Q3 2018.
  • Funds reported $45M of ALPS Medical Breakthroughs ETF stock for Q4 2018, down 47% quarter-over-quarter.
  • 8 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2018 and 13 closed out, a net change of -5 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q4 2018 was Bouchey Financial Group, an estimated $3.7M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q4 2018 was Bank of America, an estimated $8.39M sold.

Based on aggregated 13F filings for Q4 2018.